The Effect of Alcohol Consumption in Unresectable Hepatocellular Carcinoma with Transarterial Chemoembolization

Table 6

Competing risk analysis for the survival of patients after propensity score matching.

Characteristics	Competing risk analysis for survival
	Univariable analysis		Multivariable analysis
	HR (95% CI)	value	HR (95% CI)	value
Age (years)	0.991 (0.977, 1.005)	0.196
AST	1.002 (0.993, 1.010)	0.689
ALT	0.996 (0.987, 1.006)	0.432
Bilirubin	1.024 (1.005, 1.043)	0.011	1.025 (1.006, 1.045)	0.011
Albumin	0.999 (0.972, 1.027)	0.928
NLR	1.068 (1.013, 1.127)	0.016	1.004 (0.918, 1.098)	0.927
PLR	1.004 (1.001, 1.006)	0.007	1.002 (0.999, 1.005)	0.096
Maximal tumor size (cm)	1.067 (1.025, 1.111)	0.002	1.065 (1.018, 1.114)	0.006
Gender
Male	Ref	0.908
Female	1.027 (0.649, 1.625)
Smoking
Yes	Ref	0.162
No	1.255 (0.913, 1.727)
HBV infection
Yes	Ref	0.872
No	0.967 (0.647, 1.445)
HCV infection
Yes	Ref	0.768
No	0.944 (0.879, 1.267)
Cirrhosis
Yes	Ref	0.255
No	0.826 (0.595, 1.147)
Ascites
Yes	Ref	0.731
No	1.117 (0.595, 2.095)
TACE session
Once	Ref	0.030	Ref	0.061
Multiple times	0.513 (0.281, 0.937)		0.527 (0.270, 1.029)
Tumor number
1	Ref	0.224
≥2	1.254 (0.871, 1.801)
BCLC stage
A	Ref
B	1.208 (0.653, 2.237)	0.547
C	1.520 (0.797, 2.901)	0.204
AFP level
<200	Ref	0.777
≥200	1.053 (0.734, 1.511)
Child-Pugh
A	Ref	0.763
B	1.063 (0.714, 1.582)
ECOG score
0	Ref	0.167	Ref
1	1.274 (0.903, 1.798)
Alcohol
Abstinence	Ref	0.005	Ref	0.022
Consumption	1.596 (1.151, 2.185)		1.505 (1.060, 2.134)